Pershing Square
PS
58.65
-1.10
-1.84%
Pershing Square
US · PS
#856 by market cap
Listed 2026
58.65
-1.10
-1.84%
Live - 5344 symbols - heartbeat 213s ago
· 2026-10-08 07:00
Pre-market
57.68
-1.66%
After-hours
59.00
+0.60%
Overnight
59.95
+2.22%
- Market cap
- 23.46B
- P/E (TTM)i
- 1,466.25
- P/Bi
- 17.24
- EPSi
- 0.62
- Div yieldi
- 0.00%
- 52W posi
- 95%
Reader sentiment
Are you bullish or bearish on PS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 13.80, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +64.66% YoY
Margins
- Gross margin
- 94.56%
- Operating margin
- -47.25%
- Net margin
- -28.01%
Key ratios & quality
- Altman Z-Scorei
- 13.80
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | 232.03M | 316.91M | 391.87M | 455.50M | 750.01M |
| Gross profit | 91.68M | 117.00M | 169.41M | 245.56M | 309.31M | 442.33M | 709.20M |
| Selling & admin expenses | 105.52M | 199.74M | 306.12M | 395.55M | 452.60M | 389.09M | 1.06B |
| Research & development | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -13.84M | -82.75M | -136.70M | -149.99M | -143.29M | -19.69M | -354.34M |
| Pretax profit | -20.12M | -96.21M | -146.11M | -162.76M | -164.20M | 18.38M | -233.06M |
| Tax | 494.00K | 324.00K | 664.00K | 823.00K | -108.00K | 15.99M | -54.88M |
| Net profit | -20.61M | -96.54M | -146.77M | -163.58M | -164.09M | 2.39M | -178.18M |
| Basic EPS | 0 | -2 | -1 | -1 | -1 | 0 | -1 |
| Diluted EPS | -0.28 | -1.66 | -0.72 | -1.19 | -1.15 | -0.04 | -0.53 |
| Line item | 2020-09 | 2020-12 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 99.47M | 104.99M | 52.30M | 53.18M | 57.51M | 54.18M |
| Gross profit | 79.04M | 81.59M | 48.16M | 49.25M | 47.88M | 3.87M |
| Selling & admin expenses | 106.92M | 119.49M | 25.18M | 15.44M | 27.39M | 81.24M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -27.88M | -37.90M | 10.39M | 20.14M | 5.07M | -90.13M |
| Pretax profit | -33.30M | -43.44M | 21.62M | 34.79M | -157.68M | -49.81M |
| Tax | 476.00K | -361.00K | 1.79M | 1.93M | 857.18K | -9.27M |
| Net profit | -33.77M | -43.08M | 19.82M | 32.86M | -158.53M | -40.54M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.24 | -0.30 | 0.05 | 0.06 | -0.37 | -0.11 |
Balance sheet
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 44.91M | 71.62M | 266.07M | 556.83M | 566.37M | 1.21B | 808.51M |
| Cash & ST investments | 19.40M | 28.27M | 194.31M | 422.75M | 399.62M | 964.86M | 6.82M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 214.97M | 236.42M | 447.46M | 1.03B | 1.15B | 1.32B | 2.79B |
| Total current liabilities | 97.66M | 143.53M | 206.90M | 283.90M | 342.47M | 100.29M | 115.24M |
| Short-term debt | 10.00M | -- | -- | 5.75M | 10.35M | -- | -- |
| Long-term debt | 81.60M | 123.55M | 15.78M | 470.23M | 497.31M | 34.80M | 232.88M |
| Total liabilities | 522,202,000.00 | 681,497,000.00 | 238,870,000.00 | 785,793,000.00 | 949,363,000.00 | 351,534,217.00 | 1,025,147,000.00 |
| Total equity | -307.23M | -445.08M | 208.59M | 246.16M | 201.77M | 967.26M | 1.77B |
| Retained earnings | -307.22M | -445.10M | -355.45M | -458.38M | -586.46M | -- | -161.09M |
| Line item | 2020-09 | 2020-12 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 519.77M | 566.37M | -- | -- | 337.84M | 290.67M |
| Cash & ST investments | 404.96M | 399.62M | -- | -- | 46.85M | 8.91M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.08B | 1.15B | -- | -- | 990.48M | 1.81B |
| Total current liabilities | 283.13M | 342.47M | -- | -- | 33.49M | 11.71M |
| Short-term debt | 9.18M | 10.35M | -- | -- | -- | -- |
| Long-term debt | 490.36M | 497.31M | -- | -- | 34.80M | 231.99M |
| Total liabilities | 870,081,000.00 | 949,363,000.00 | -- | -- | 105,998,320.00 | 403,478,249.00 |
| Total equity | 211.51M | 201.77M | -- | -- | 884.48M | 1.41B |
| Retained earnings | -550.99M | -586.46M | -- | -- | -- | 24.96M |
Cash flow
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.47M | -12.14M | -5.90M | -11.73M | 9.09M | 294.48M | -134.23M |
| Depreciation & amortization | 13.65M | 16.66M | 18.99M | 16.49M | 22.02M | 2.78M | 2.30M |
| Free cash flow | -7.93M | -20.47M | -18.03M | -28.24M | -34.16M | 292.92M | -134.68M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 110.00K | 675.00K | 332.08M | -- | -- | 748.42M | -164.39M |
| Ending cash balance | 19.40M | 28.48M | 211.07M | 119.43M | 151.94M | 964.98M | 55.52M |
| Line item | 2020-09 | 2020-12 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.35M | 2.40M | 65.07M | -258.20M | 87.90M | 25.43M |
| Depreciation & amortization | 5.26M | 6.46M | 577.58K | 2.87M | 579.24K | 18.08M |
| Free cash flow | -14.86M | -4.03M | 65.02M | -258.42M | 87.88M | 25.42M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -88.54M | -27.12M | -90.57M | -27.49M |
| Ending cash balance | 118.22M | 151.94M | 940.85M | 47.74M | 46.96M | 9.03M |
Returns & efficiency
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -79.22 | -73.12 | -1.46 | -15.72 |
| ROA %i | -12.53 | -71.04 | -76.02 | -15.23 | -11.73 | -1.07 | -10.22 |
| ROIC %i | -- | -- | -- | -24.07 | -13.92 | -3.26 | -13.33 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -10.47 | -50.68 | -52.19 | -43.92 | -34.42 | 4.71 | -29.08 |
| FCF / sales %i | -- | -- | -- | -- | -- | 64.31 | -- |
| Current ratioi | 0.46 | 0.50 | 1.29 | 1.96 | 1.65 | 12.08 | 7.02 |
| Quick ratioi | 0.43 | 0.46 | 1.25 | 1.85 | 1.51 | 12.07 | 7.00 |
| Debt / assetsi | 42.61 | 52.26 | 3.53 | 47.21 | 50.57 | 6.15 | 9.87 |
| LT debt / equityi | -- | -- | 15.56 | 263.08 | 341.67 | 8.39 | 16.16 |
| Interest coveragei | -2.18 | -7.25 | -17.74 | -5.91 | -4.60 | 6.94 | -14.58 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 33.96 | 32.93 | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2020-09 | 2020-12 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -68.55 | -73.12 | -- | -- | -45.02 | -32.61 |
| ROA %i | -11.91 | -11.73 | -- | -- | -38.11 | -24.48 |
| ROIC %i | -14.28 | -13.92 | -- | -- | -40.21 | -26.07 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -35.98 | -34.42 | -- | -- | -52.63 | -63.49 |
| FCF / sales %i | -- | -- | -- | -- | -- | 22.75 |
| Current ratioi | 1.84 | 1.65 | -- | -- | 10.09 | 24.83 |
| Quick ratioi | 1.70 | 1.51 | -- | -- | 9.97 | 24.43 |
| Debt / assetsi | 53.16 | 50.57 | -- | -- | 5.70 | 13.96 |
| LT debt / equityi | 324.45 | 341.67 | -- | -- | 6.73 | 18.59 |
| Interest coveragei | -4.67 | -4.60 | -- | -- | -26.70 | -28.54 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United States61.50%
Europe, Middle East and Africa28.54%
Other Foreign Locations9.96%
Quote time 2026-10-08 07:00:09 · For reference only, not investment advice and not tailored to your situation.